Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

16.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.9K
The Electron Transport Chain01:30

The Electron Transport Chain

18.8K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
18.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

8.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

8.6K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Borylated 5-Membered Ring Iminosugars: Synthesis and Biological Evaluation for Glycosidase Inhibition and Anticancer Properties for Application in Boron Neutron Capture Therapy (BNCT)-Part 2.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Borylated Five-Membered Ring Iminosugars: Synthesis, Spectroscopic Analysis, and Biological Evaluation for Glycosidase Inhibition and Anticancer Properties for Application in Boron Neutron Capture Therapy (BNCT)-Part 1.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Borylated 5-Membered Ring Iminosugars: Detailed Nuclear Magnetic Resonance Spectroscopic Characterisation, and Method for Analysis of Anomeric and Boron Equilibria.

Molecules (Basel, Switzerland)·2025
Same author

Borylated Monosaccharide 3-Boronic-3-deoxy-d-galactose: Detailed NMR Spectroscopic Characterisation, and Method for Spectroscopic Analysis of Anomeric and Boron Equilibria.

International journal of molecular sciences·2024
Same author

Is ASCT2 a Suitable Vector for the Selective Delivery of Anticancer Drugs? Modification of Glutamine at Either the Carboxylate or the Side Chain Hinders Binding and Transport.

ChemMedChem·2024
Same author

Placental Element Content Assessed via Synchrotron-Based X-ray Fluorescence Microscopy Identifies Low Molybdenum Concentrations in Foetal Growth Restriction, Postdate Delivery and Stillbirth.

Nutrients·2024

Related Experiment Video

Updated: Nov 16, 2025

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
06:55

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Published on: June 7, 2020

3.2K

Warburg Effect Targeting Co(III) Cytotoxin Chaperone Complexes.

Alexandra Glenister1, Catherine K J Chen1, David J Paterson2

  • 1School of Chemistry, University of Sydney, Camperdown, NSW 2006, Australia.

Journal of Medicinal Chemistry
|February 23, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a novel glucose-based vector for targeted cancer therapy. The developed complex shows promise for caged and targeted delivery of potent anticancer agents, enhancing drug efficacy.

More Related Videos

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

3.0K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.0K

Related Experiment Videos

Last Updated: Nov 16, 2025

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
06:55

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Published on: June 7, 2020

3.2K
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

3.0K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.0K

Area of Science:

  • Biochemistry
  • Materials Science
  • Oncology

Background:

  • Targeted drug delivery systems are crucial for improving cancer treatment efficacy and reducing side effects.
  • Glucose transporters are often upregulated in cancer cells, presenting an opportunity for targeted delivery.

Purpose of the Study:

  • To develop a glucose-based vector for targeted delivery of anticancer agents.
  • To investigate the cellular uptake and mechanism of action of a novel cobalt complex conjugated to a glucose-based ligand.

Main Methods:

  • Synthesis of a glucose-conjugated tris(methylpyridyl)amine ligand (tpa(CONHPEGglucose)1).
  • Formation of a Co(III) complex with the ligand and coumarin-343 hydroximate (C343ha).
  • Evaluation of glucose-dependent cellular accumulation and antiproliferative activity in DLD-1 colon cancer cells using X-ray fluorescence and visible light fluorescence.

Main Results:

  • The Co(III) complex, [Co(C343ha){tpa(CONHPEGglucose)1}]Cl, demonstrated glucose-dependent cellular accumulation in DLD-1 cells.
  • Cellular uptake was slower compared to glucose-null and glucosamine analogues, indicating specific glucose targeting.
  • Distribution studies confirmed uptake by rapidly dividing cells, with subsequent release of C343ha and trapping of the Co{tpa(CONHPEGglucose)1} moiety.

Conclusions:

  • The glucose-based vector facilitates targeted delivery of anticancer agents to cancer cells.
  • The Co{tpa(CONHPEGglucose)1} moiety shows potential for the caged and targeted delivery of highly toxic anticancer agents, offering a novel therapeutic strategy.